1. Romania Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Ropharma SA

Ropharma SA

BBVB:RPH
0.25
RON
+0.03
(+14.55%)
82.31MMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
0.82
0.83
0.85
0.87
0.92
0.95
1.14
1.41
1.41
1.52
1.79
1.97
2.33
- -
Basic EPS, GAAP
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.01
0.01
0.02
0.02
0.02
- -
- -
Free Cash Flow per Basic Share
-0.04
0.11
-0.04
-0.02
0.04
-0.06
-0.02
-0.07
-0.05
-0.04
0.02
0.05
0.05
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
- -
Book Value per Share
0.21
0.23
0.24
0.25
0.28
0.31
0.34
0.36
0.39
0.42
0.45
0.47
0.48
0.48
Tangible Book Value per Share
0.19
0.19
0.21
0.18
0.21
0.24
0.26
0.27
0.3
0.33
0.35
0.36
0.36
0.36
Basic Weighted Avg Shares
510
510
510
507
511
511
511
511
510
510
511
511
511
516
Sales/Revenue/Turnover
418
421
431
440
469
488
582
720
716
777
913
1,006
1,191
- -
Operating Margin (%)
1.98
2.24
2.54
2.1
2.45
2.82
1.91
1.15
2.03
2.33
1.06
1.8
2.33
- -
Depreciation Expense
6
7
7
9
9
9
10
19
23
23
24
27
29
- -
Net Income, GAAP
7
7
7
9
10
12
12
8
7
11
9
8
-2
- -
Effective Tax Rate (%)
24.77
19.98
20.95
15.98
8.52
12.78
14.48
29.82
30.15
14.48
27.38
14.69
75.04
- -
Profit Margin (%)
1.76
1.77
1.73
1.96
2.2
2.38
2.08
1.04
0.94
1.38
1.01
0.77
-0.14
- -
Working Capital
28
18
21
20
28
29
2
-17
1
5
4
6
31
31
LT Debt
10
4
1
6
8
12
28
85
82
80
86
100
106
106
Total Equity
111
118
127
131
152
169
183
189
202
220
233
252
259
259
Return on Invested Capital (%)
5.81
6
5.51
6.7
7.66
7.79
6.02
3.1
2.55
4.61
2.6
4.41
1.61
- -
Return on Capital (%)
5.99
5.33
5.47
6.26
5.93
5.69
5.37
4.19
3.27
3.59
3.64
2.13
-1.76
- -
Return on Common Equity (%)
7.45
6.64
6.22
6.94
7.65
7.62
7.26
4.23
3.56
5.23
4.15
3.27
-0.71
- -

Capital Structure

RON

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
ST Debt
64
64
57
LT Borrowings
17
16
22
LT Finance Leases
83
86
83
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
511
511
511
Market Capitalization
102
102
82

Working Capital

RON

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
Total Current Assets
452
526
602
Cash, Cash Equivalents & STI
17
32
20
Accounts Receivable, Net
251
261
320
Inventories
168
209
226
Total Current Liabilities
446
520
571
Payables & Accruals
- -
- -
- -
ST Debt
64
64
57
Deferred Revenue
- -
- -
- -

Growth Rates

RON

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.51%
6.6%
2.97%
Free Cash Flow
-52.08%
-20.48%
0.37%
Net Income, GAAP
-8.95%
-20.82%
-122.36%
Sales/Revenue/Turnover
10.97%
10.8%
18.35%
Total Cash Common Dividend
- -
- -
65.9%

Quarterly Revenue

RON

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
133
304
- -
- -
913
2023
151
- -
- -
- -
1,006
2024
- -
- -
- -
- -
1,191

Quarterly Earnings Per Share

RON

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
0.02
2023
- -
- -
- -
- -
0.02
2024
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

RON

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
0.01

Company Description

Company Profile APIChatGPT
CEO
Mihai Miron
Full Time Employees
1,751
Sector
Distribution services
Industry
Medical distributors
Address
Brasov Romania
IPO Date
Jan 13, 1997
Website
ropharma.ro
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Ropharma SA is a Romania-based integrated healthcare and pharmaceutical company engaged in the manufacturing, wholesale distribution, retail dispensing, and provision of medical care services. Founded in 1991 and headquartered in Brasov, Romania, the company operates through four primary business segments: Retail Pharmacy, Wholesale Distribution, Pharmaceutical Manufacturing, and Healthcare Services. The company's product and service portfolio includes prescription (Rx) pharmaceuticals; over-the-counter (OTC) medicines; dietary and nutritional supplements, including vitamins, minerals, and botanical extracts; apitherapy and natural bee-derived formulations; dermato-cosmetics and personal hygiene products; infant nutrition, baby care, and dietetic products; medical devices, diagnostic tests, and clinical consumables; pharmaceutical warehousing, cold-chain distribution, and supply chain logistics for institutional and independent healthcare providers; third-party contract manufacturing, formulation development, and primary and secondary packaging services; and private outpatient medical services, including multi-specialty clinical consultations, laboratory diagnostic testing, occupational health evaluations, and preventive care programs. Ropharma SA distributes products nationwide across Romania and operates a retail network of more than 130 community pharmacies situated primarily throughout the Transylvania and Moldavia regions, supplemented by an integrated e-commerce platform. The company's manufacturing footprint includes production facilities operated directly and through its subsidiary Eurofarmaco SA, producing tablets, capsules, powders, and liquid dosage forms. In recent developments, Ropharma SA has expanded its proprietary healthcare portfolio with the rollout of new preventative dietary supplements and natural health formulations, modernized and expanded its manufacturing lines to enhance production capacity under Good Manufacturing Practice (GMP) standards, upgraded its retail pharmacy network with digital customer management and omni-channel fulfillment capabilities, and implemented operational efficiency programs, including the installation of solar photovoltaic systems across key logistics hubs and retail facilities to reduce operational expenditures and improve energy sustainability.